07/23/2021 10:33 AM
Clarín.com
Society
Updated 07/23/2021 11:03
The European Medicines Agency (EMA) approved on Friday the use of the Modern vaccine against the coronavirus for young people between 12 and 17 years old, the second drug authorized for adolescents in the 27 countries of the European Union (EU).
"The EMA's Committee for Medicinal Products for Human Use (CHMP) recommended granting an extension to the covid-19 Spikevax vaccine (formerly known as Covid-19 Vaccine Moderna) to include its use among minors 12 to 17 years old," he stated. the European regulator in a statement.
It is the second drug after Pfizer authorized for adolescents in the 27 countries of the European Union (EU).
The announcement opens the door so that adolescents with comorbidities in Argentina can begin to be vaccinated.
In the morning, Health Minister Carla Vizzotti had referred to this possibility.
"We must tell the parents of adolescents that we are working to have vaccines (for boys). There are prospects for the approval of vaccines such as Moderna's, which has clinical trials from 12 to 17. It is very similar to Pfizer's, It has the same platform. A positive opinion is expected, "the official revealed.
"That is the reason why the 3.5 million vaccines that we receive donated from the United States are waiting to define on Tuesday with the Federal Health Council emergency authorizations from any of the entities in Europe or the United States, the possibility of using them for adolescents with comorbidities. It is the strategy we are planning. It is not that we have them without using them because we like to have them, "he explained in a dialogue with Radio 10.
Source AFP
News in development.
AFG
Look also
AstraZeneca's vaccine is "highly effective" against Delta and Beta variants
